MDT Chart

1 Month

	Date	Diff
	2025-05-02	+1.54 %
The article discusses the recent rise of Critical Metals Corp's stock, which was up by 1.54%, following the appointment of several key executives and a binding agreement with major shareholders to secure their holdings for 180 days, signaling confidence in the company's strategic projects in the critical minerals sector. Medtronic (MDT) stock likely increased due to positive market sentiment and developments in management that could boost investor confidence in Critical MetalsCorp’s plans.
	2025-04-29	+0.67 %
The article discusses the comparative strengths of two small-cap medical companies, PetVivo and Orchestra BioMed, highlighting differences in volatility, institutional ownership, and market recommendations, while mentioning that Medtronic collaborates with Orchestra BioMed on product development. Medtronic (MDT) stock might be experiencing an uptick due to positive sentiment toward its collaboration with Orchestra BioMed, particularly as analysts favor Orchestra for its growth potential, which may reflect positively back on Medtronic's involvement.
	2025-04-22	+1.92 %
Medtronic's (MDT) stock rose by 1.92% last night, likely driven by increased investor interest due to its inclusion among the top artificial intelligence stocks to watch, highlighting the company's ongoing investment in innovative medical therapies.
	2025-04-16	+0.4 %
Medtronic (MDT) stock rose by 0.4% following the announcement of positive five-year outcomes from the Evolut Low Risk Trial, which demonstrated improved clinical results in patients receiving the Evolut transcatheter aortic valve replacement (TAVR) system compared to traditional surgery. Medtronic (MDT) stock rose by 0.4% due to investor optimism and positive sentiment surrounding the medical devices sector amid ongoing discussions about tariffs on pharmaceuticals, as companies like Johnson & Johnson are downplaying tariff risks and emphasizing the importance of domestic manufacturing investment, which may benefit Medtronic's business outlook.
	2025-04-14	+1.59 %
The article discusses the recent performance of Intel stock, which has seen a slight increase amidst challenging market conditions, attributing this rise to investor confidence due to new leadership and board changes aimed at enhancing management experience in semiconductors. The increase in Medtronic (MDT) stock is likely attributed to market trends and investor sentiment towards the company, particularly as it may be benefiting from broader market volatility and potential future strategic initiatives that restore confidence among shareholders.
	2025-04-10	-3.21 %
Medtronic (MDT) stock declined by 3.21% amid heightened tensions from the escalating US-China trade war, which has led to increased tariffs and uncertainty in the global market, affecting investor confidence.
	2025-04-07	+0.33 %
The article discusses the importance of wisdom in leadership amidst today's complex challenges but does not specifically address Medtronic's (MDT) recent stock increase of 0.33%. The rise in Medtronic's stock could be attributed to various factors such as positive market sentiment, investor confidence in the company's performance, or broader trends in the healthcare sector.
	2025-04-01	-1.52 %
Medtronic (MDT) stock fell by 1.52% last night, although the article provided does not elaborate on the specific reasons for this decline. However, potential factors could include market reactions to broader economic conditions, company-specific news, competitive pressures, or changes in investor sentiment.
	2025-03-31	+2.54 %
The article discusses Orchestra BioMed Holdings’ recent financial results and developments, particularly highlighting their innovative AVIM therapy for hypertension and Virtue SAB program, which could contribute to the commercial success of their partnership with Medtronic. Medtronic's stock (MDT) likely rose by 2.54% due to positive advancements and potential clinical outcomes related to Orchestra BioMed's therapies, which could enhance its market position and profitability in the medical device sector. The article reports on the successful results of a trial investigating whether a less intense antiplatelet regimen is non-inferior to the standard regimen after drug-coated balloon angioplasty, with significant findings leading to implications for medical treatment strategies. Medtronic (MDT) stock may have risen by 2.54% due to positive developments in healthcare innovations, particularly related to their drug-coated balloon technology, suggesting potential market confidence in their product advancements following the trial results.
	2025-03-25	-1.71 %
Medtronic (MDT) stock fell by 1.71% due to a broader market correction impacting growth stocks, as well as trepidation regarding tariff implications from recent political statements, amidst a backdrop of fluctuating stock performance in Asian markets.
	2025-03-24	-0.22 %
The article discusses Acutus Medical's significant revenue growth and operational changes in 2024, but does not directly explain Medtronic (MDT) stock's recent decline of -0.22%. However, potential reasons for the decline could be related to market reactions to industry pressures, such as the restructuring plans and financial performance of Acutus, which is tied to Medtronic through their distribution agreement.
	2025-03-17	+0.3 %
Medtronic (MDT) stock increased by 0.3% due to a mix of positive analyst ratings, including upgrades from Citigroup and Robert W. Baird, which likely boosted investor confidence, along with the company's recent earnings surpassing expectations.
	2025-03-14	+0.8 %
The article discusses the perceived cowardice of wealthy business leaders in relation to their handling of Trump’s economic policies and the impact on their wealth, reflecting on the contrasting views of some business executives who fear public backlash and the consequences of criticizing Trump. Medtronic (MDT) stock rose 0.8% possibly as a result of overall positive market sentiment or specific company developments that were influenced by CEO Bill George's insight into the current economic climate.
	2025-03-13	+0.9 %
The article discusses that Medtronic (MDT) stock was up 0.9% in response to the positive progress and advancements made by Anteris Technologies in its heart valve technology and preparations for its upcoming pivotal trial, which could enhance competition in the market. Medtronic's stock may have increased due to investor optimism surrounding competitive developments related to the DurAVR® THV system, which could impact the market dynamics for heart valve treatments that Medtronic participates in.
	2025-03-12	-1.9 %
Medtronic (MDT) stock fell by 1.9%, possibly due to investor concerns about the high costs associated with robotic-assisted surgery systems, which pose a significant barrier to market growth despite advancements in technology. Medtronic (MDT) stock fell by 1.9%, which may be attributed to concerns about Elon Musk's management capabilities as he juggles multiple high-profile ventures and government involvement, leading some investors to worry about the distraction and its potential impact on the performance of companies like Tesla, which has also seen a significant decline in its stock value.
	2025-03-10	-0.74 %
Medtronic's (MDT) stock fell by 0.74% likely due to increasing competition and advancements in the artificial intelligence (AI) healthcare market, which might have raised concerns regarding the company's growth opportunities in a rapidly evolving industry.
	2025-03-05	+1.11 %
Medtronic (MDT) stock rose by 1.11% following an upgrade by Citigroup from a neutral rating to buy, with a target price increase from $92 to $107, signaling positive investor sentiment and potential growth prospects for the company.
	2025-02-27	+0.18 %
Medtronic (MDT) stock rose by 0.18% following positive earnings results that exceeded analyst expectations and favorable updates from several analysts regarding its price targets and ratings. The upward movement can also be attributed to recent institutional interest, with several funds adjusting their stakes in the company.
	2025-02-21	+2.27 %
Medtronic's stock (MDT) rose by 2.27% following a better-than-expected earnings announcement, with an EPS of $1.39 surpassing the consensus estimate of $1.36, indicating positive financial performance despite slightly lower revenue than expected.
	2025-02-19	+1.08 %
Medtronic (MDT) stock rose by 1.08% to $93.02, driven by strong trading volume and its solid performance in the medical device market, which reflects investors' confidence in the company's growth prospects in the health care sector.
	2025-02-14	+0.66 %
The article discusses the success of Fastenal, highlighting founder Bob Kierlin's leadership and business strategies that transformed the company into a billion-dollar leader, paralleling his achievements with those of notable entrepreneurs including Earl Bakken of Medtronic. Medtronic (MDT) stock increased by 0.66% likely due to positive market sentiments or reactions to its performance, possibly influenced by the overall successful narratives of influential leaders like Kierlin in the industry.
	2025-02-11	+0.4 %
Medtronic (MDT) stock increased by 0.4% last night, likely due to positive market sentiment and developments in the healthcare sector, including advancements in AI and digital twins that could enhance medical device designs and efficiency.
	2025-02-05	+0.79 %
Medtronic (MDT) stock rose by 0.79% last night, likely due to positive investor sentiment and analysts' confidence in its performance in the medical technology sector, particularly regarding its advancements in AI applications.
	2025-02-04	+0.49 %
Medtronic (MDT) stock rose by 0.49% due to a significant increase in institutional investment, with Chicago Partners Investment Group LLC raising its holdings by 43.9% and other investors also boosting their positions, which reflects growing confidence in the company's performance and stability.
	2025-01-31	-1.27 %
Medtronic (MDT) stock fell by 1.27% due to significant selling activity from institutional investors, including a 59.5% reduction in holdings by Kingswood Wealth Advisors, along with insider stock sales, indicating potential concern over the company's performance or future prospects.
	2025-01-28	-0.52 %
Medtronic (MDT) shares have started 2025 positively with a 13% year-to-date increase, despite a recent dip of -0.52% attributed to ongoing challenges and underperformance in its diabetes segment.
	2025-01-24	+1.05 %
Medtronic (MDT) stock rose by 1.05% due to strong institutional ownership and favorable analyst recommendations, indicating positive long-term growth potential compared to its competitor, Precision Optics (POCI).
	2025-01-17	+1.06 %
Medtronic plc (NYSE: MDT) stock rose by 1.06% following increased institutional investments, as several large funds raised their stakes in the company, indicating positive sentiment toward its future performance and financial stability.
	2025-01-16	+2.06 %
Medtronic plc (NYSE:MDT) saw a 2.06% increase in stock price due to a combination of positive earnings results that exceeded analysts’ expectations and continued interest from institutional investors, despite some selling by others. Medtronic (MDT) stock rose by 2.06% due to the Centers for Medicare & Medicaid Services initiating a national coverage analysis for renal denervation, following Medtronic's request to support access to its Symplicity™ Spyral renal denervation system, which targets hypertension. Medtronic (MDT) stock rose 2.06% following increased institutional investment and changes to positions by hedge funds during the fourth quarter, indicating strong market interest and confidence in the company's performance. Medtronic plc (NYSE: MDT) stock rose 2.06% due to increased institutional holdings, including a significant boost from Wedmont Private Capital and favorable analyst ratings, which reflect positive earnings performance and revenue growth.
	2025-01-15	+0.18 %
Medtronic (MDT) stock increased by 0.18% likely due to favorable earnings results surpassing estimates and ongoing investor interest despite some stock trimming by large institutional investors. Medtronic plc (NYSE: MDT) experienced a 0.18% increase in stock price, attributed to recent hedge fund activities showing a mix of trimming and boosting positions in the company, along with solid quarterly earnings results that exceeded analyst expectations. Medtronic (MDT) stock rose by 0.18% likely due to positive market sentiment following the performance and growth prospects of competing healthcare companies making headlines, as well as traders seeking growth stocks in the sector.
	2025-01-13	+1.4 %
Medtronic (MDT) stock rose by 1.4% likely due to positive revenue performance and business developments announced by Inspire Medical Systems, which is relevant in the medical technology sector that Medtronic operates in, alongside leadership changes and initial revenue guidance that indicate growth potential. Medtronic (MDT) stock rose by 1.4% following positive quarterly earnings results that exceeded analyst expectations, indicating strong performance and potential growth despite an executive's recent sale of shares, which reflects ongoing institutional investment interest in the company.
	2025-01-10	-2.44 %
Medtronic (MDT) stock declined by 2.44% due to the overall challenging market conditions affecting the healthcare sector, compounded by rising inflation and interest rates impacting consumer spending and investment in medical technologies.
	2025-01-07	+0.04 %
Medtronic (MDT) stock rose by 0.04% due to increased institutional investment, with several large funds enhancing their holdings, alongside a recent positive earnings report that exceeded analysts' expectations.
	2025-01-06	-1.37 %
The article discusses the performance and comparisons of Atlassian and Materialise stocks, but does not provide specific reasons for Medtronic (MDT) stock's decline of -1.37%. Medtronic's stock may have gone down due to broader market trends, investor sentiment, or company-specific events, none of which are detailed in the provided text.
	2025-01-03	+0.91 %
Medtronic plc (MDT) stock rose by 0.91% due to a combination of favorable earnings performance, positive analyst upgrades in price targets, and significant institutional investment activity.
	2025-01-02	+0.43 %
Medtronic plc's stock (MDT) rose by 0.3% to $79.84 due to a combination of positive earnings results exceeding analyst estimates, favorable upgrades from various equities analysts, and strong institutional investor interest, which collectively signal a stable outlook for the company.
	2024-12-27	-1.05 %
Medtronic (MDT) stock fell by 1.05% amid mixed analyst ratings and recent price target reductions by several research firms, contributing to market uncertainty surrounding its performance.
	2024-12-19	-0.05 %
Medtronic plc (NYSE: MDT) stock fell by 0.1% after Truist Financial lowered its price target from $93.00 to $89.00, maintaining a hold rating on the stock. The decline is attributed to the downgrade from Truist Financial. Medtronic plc (MDT) stock experienced a slight decline of 0.05% amid an unusual surge in put options trading, which rose by 110%, indicating heightened bearish sentiment and concerns among traders about potential future declines in the stock's performance.
	2024-12-17	+0.02 %
The article discusses the rising prominence of artificial intelligence (AI) in medical diagnostics and its potential impact on healthcare outcomes, highlighting that Medtronic's stock (MDT) saw a slight increase of 0.02%. Medtronic's stock likely went up due to the ongoing advancements and integration of AI technologies in healthcare, which improve operational efficiency and patient care, positioning the company favorably in a rapidly evolving industry.
	2024-12-16	-1.37 %
Medtronic (MDT) stock declined by 1.37% as part of a broader market pullback, driven by cautious investor sentiment ahead of the U.S. Federal Reserve's FOMC meeting and mixed global economic signals.
	2024-12-09	-0.06 %
Medtronic (MDT) stock dropped by 0.06% amid news that rival EOFlow was ordered to pay $452 million to Insulet for stealing trade secrets related to insulin pumps, which raises concerns over Medtronic's previous acquisition plans for EOFlow that were canceled due to multiple breaches of agreements.
	2024-12-06	-0.15 %
Medtronic (MDT) stock experienced a slight decline of 0.15%, which may be attributed to market factors influencing investor sentiment or performance comparisons with other medical companies like Orchestra BioMed and Tandem Diabetes Care, suggesting a broader industry sentiment affecting MDT. The article discusses the recent firing of Intel CEO Pat Gelsinger amid frustrations with the board's direction, highlighting the lack of semiconductor expertise among board members and questioning their strategy, suggesting that the desire for short-term shareholder value is leading Intel toward potential disintegration. Medtronic (MDT) stock fell by 0.15% likely due to market reactions to ongoing uncertainties in the semiconductor sector, particularly influenced by Intel's leadership changes and strategic shifts.
	2024-12-04	-0.46 %
Medtronic (MDT) stock fell by 0.46% due to mixed analyst ratings and potential market adjustments following recent earnings reports and institutional trading activity.
	2024-12-02
The article discusses a comparison between Materialise and MeridianLink as investment options, highlighting that while Materialise has higher earnings, MeridianLink is trading at a lower price-to-earnings ratio, making it the more affordable stock; however, it does not explain why Medtronic (MDT) stock was down 0.0%. The decline in Medtronic's stock may be attributed to various factors such as market trends, investor sentiment, or specific company-related events, but the article does not provide information on those aspects. The article discusses Astorg's acquisition of Hamilton Thorne and Cook Medical's Reproductive Health business to create a global leader in assisted reproductive technology. Medtronic (MDT) stock went down likely due to market reactions to external events or company-specific concerns not detailed in the article.
	2024-11-27	+0.69 %
The article discusses the entrepreneurial lessons learned from Mark Zuckerberg's success with Meta, highlighting the importance of entering emerging trends and pivoting strategies effectively. Medtronic (MDT) stock may have gone up by 0.69% due to positive investor sentiment driven by the broader trend in the medical electronics industry, which the company's co-founder Earl Bakken capitalized on, as well as strong performance indicators or developments related to Medtronic's ongoing innovations and market positioning. Medtronic (MDT) stock rose by 0.69% following the company's Q2 fiscal 2025 results, which exceeded revenue and earnings estimates, driven by strong adoption of new products like the MiniMed 780G and significant growth in its diabetes and neuroscience segments.
	2024-11-26	-0.08 %
The article discusses the appointment of Mr. Scott R. Ward to InspireMD's Board of Directors, which may indirectly impact Medtronic (MDT) stock negatively, as he previously held senior positions there and his departure could raise concerns about Medtronic's leadership stability and strategic direction.
	2024-11-25	-0.53 %
Medtronic (MDT) stock declined by 0.53% due to potential investor concerns related to ongoing challenges in the healthcare sector, including rising treatment costs for chronic conditions like hypertension as highlighted in a recent study.
	2024-11-22	+1.73 %
Medtronic (MDT) stock rose by 1.73% after it reported stronger-than-expected quarterly earnings, with EPS of $1.26 exceeding estimates, as well as a 5.2% revenue increase year-over-year, despite a recent price target reduction by Robert W. Baird.
	2024-11-21	+0.75 %
Medtronic (MDT) stock rose by 0.75% following a positive earnings report that exceeded expectations, with the company posting $1.26 EPS and $8.40 billion in revenue, which likely boosted investor confidence. Medtronic (MDT) stock rose by 0.75% following the company's strong quarterly earnings report, which exceeded analysts' expectations for both earnings per share and revenue growth.
	2024-11-20	-1.05 %
Medtronic (MDT) stock decreased by 1.05% due to market dynamics and competitive pressures within the rapidly evolving healthcare AI sector, which is characterized by significant innovation and investment in new technologies by various companies.
	2024-11-19	-2.96 %
Medtronic (MDT) stock experienced a decline of -2.96% as investors responded to negative market sentiments influenced by geopolitical tensions and a general downturn in equities, exacerbated by foreign institutional investors offloading a significant amount of equities. Medtronic (MDT) stock declined by 2.96% likely due to broader market pressures and investor sentiment, amidst factors including profit-taking after its recent performance and concerns regarding external economic conditions, such as foreign institutional selling in equities. Medtronic (MDT) stock fell by 2.96% despite receiving multiple price target upgrades from various analysts, indicating investor uncertainty or market reactions overshadowing the positive analyst outlooks. Medtronic (MDT) stock dropped 2.96% despite beating fiscal second-quarter expectations due to a supplier issue that adversely affected its cardiac ablation division, leading to flat sales and insufficient new product performance to offset declines in legacy products. Medtronic (MDT) stock declined by 2.96% due to market volatility and decreased trading volume, despite recent analyst upgrades and positive quarterly earnings reports.
	2024-11-18	+0.07 %
Medtronic (MDT) stock rose by 0.07% despite JPMorgan Chase lowering its target price from $99 to $96, as other analysts have provided more optimistic ratings and target price increases, contributing to a mixed sentiment around the stock. Medtronic (MDT) stock rose by 0.07% ahead of its upcoming earnings announcement, where analysts expect the company to report earnings of $1.24 per share, driven by recent positive earnings results and analyst upgrades.

1
500 / page